Innovative Targeted and Immune-Mediated Cancer Therapies

Pipeline

Developing first-in-class oral drug therapeutics with broad potential benefit for cancer patients

Learn more

News

February 4, 2026
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets

January 20, 2026
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders

November 26, 2025
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules

Events

Tuesday, December 3RD, 2024 at 9:00 AM Eastern
Piper Sandler 36th Annual Healthcare Conference
Listen: Webcast

Thursday, June 20TH, 2024 at 8:30 AM Eastern
Amezalpat (TPST-1120) Global Randomized Phase 1b/2 Combination Study Update Call
Listen: Webcast
Download: Presentation [pdf]

Wednesday, October 11TH, 2023 at 8:30 AM Eastern
TPST-1120 Global Randomized Phase 1b/2 Combination Study Data Call
Listen: Webcast
Download: Presentation [pdf]